Use of bone pate and bioactive glass granules for mastoid obliteration in cholesteatoma surgery
Introduction and objective: Mastoid obliteration technique combines the advantages of canal wall-up (CWU) and canal wall-down (CWD) approaches in the surgery of chronic suppurative otitis media with cholesteatoma. We aim to demonstrate our experience with mastoid obliteration technique using bone dust and BonAlive® (S53P4) bioactive glass granule in a comparative prospective clinical study. Patients and methods: Between 1st of March 2012 and 31st of November 2021, mastoid obliteration surgery was performed in 14 patients using bone dust (7 cases) and BonAlive® granule (7 cases). Prior to these interventions, the patients had undergone more than three ear surgeries (CWU and CWD) generally in both groups. Changes of complaints, audiological results, and changes in quality of life were analysed in both groups, postoperatively. Results: Having performed the mastoid obliteration technique, cochlear damage did not occur in either patient group. Long-term ear discharge and vertigo were occasionally observed after performing obliteration with bone dust. However, these complaints disappeared after a while. Complications were not reported in the case of obliteration with BonAlive®. Outstanding improvement was experienced in both groups. Conclusion: In our practice, mastoid obliteration surgery, using either bone dust or BonAlive® granule, has proved to.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:163 |
|---|---|
| Enthalten in: |
Orvosi hetilap - 163(2022), 21 vom: 22. Mai, Seite 838-845 |
| Sprache: |
Ungarisch |
|---|
| Weiterer Titel: |
Mastoidobliterációhoz használt csontpor és bioaktív üveggranulátum a cholesteatoma sebészetében |
|---|
| Beteiligte Personen: |
Gerlinger, Imre [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 24.05.2022 Date Revised 19.12.2022 published: Electronic-Print Citation Status MEDLINE |
|---|
| doi: |
10.1556/650.2022.32477 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34120787X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34120787X | ||
| 003 | DE-627 | ||
| 005 | 20231226011242.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||hun c | ||
| 024 | 7 | |a 10.1556/650.2022.32477 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1137.xml |
| 035 | |a (DE-627)NLM34120787X | ||
| 035 | |a (NLM)35598213 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a hun | ||
| 100 | 1 | |a Gerlinger, Imre |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Use of bone pate and bioactive glass granules for mastoid obliteration in cholesteatoma surgery |
| 246 | 3 | 3 | |a Mastoidobliterációhoz használt csontpor és bioaktív üveggranulátum a cholesteatoma sebészetében |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.05.2022 | ||
| 500 | |a Date Revised 19.12.2022 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Introduction and objective: Mastoid obliteration technique combines the advantages of canal wall-up (CWU) and canal wall-down (CWD) approaches in the surgery of chronic suppurative otitis media with cholesteatoma. We aim to demonstrate our experience with mastoid obliteration technique using bone dust and BonAlive® (S53P4) bioactive glass granule in a comparative prospective clinical study. Patients and methods: Between 1st of March 2012 and 31st of November 2021, mastoid obliteration surgery was performed in 14 patients using bone dust (7 cases) and BonAlive® granule (7 cases). Prior to these interventions, the patients had undergone more than three ear surgeries (CWU and CWD) generally in both groups. Changes of complaints, audiological results, and changes in quality of life were analysed in both groups, postoperatively. Results: Having performed the mastoid obliteration technique, cochlear damage did not occur in either patient group. Long-term ear discharge and vertigo were occasionally observed after performing obliteration with bone dust. However, these complaints disappeared after a while. Complications were not reported in the case of obliteration with BonAlive®. Outstanding improvement was experienced in both groups. Conclusion: In our practice, mastoid obliteration surgery, using either bone dust or BonAlive® granule, has proved to | ||
| 650 | 4 | |a Clinical Study | |
| 650 | 4 | |a Comparative Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a BonAlive® granules | |
| 650 | 4 | |a BonAlive® granulátum | |
| 650 | 4 | |a bone pate | |
| 650 | 4 | |a canal wall-down tympanoplasty | |
| 650 | 4 | |a canal wall-up tympanoplasty | |
| 650 | 4 | |a conductive hearing loss | |
| 650 | 4 | |a csontpor | |
| 650 | 4 | |a idegi halláscsökkenés | |
| 650 | 4 | |a kevert típusú halláscsökkenés | |
| 650 | 4 | |a mixed-type hearing loss | |
| 650 | 4 | |a nyitott technikájú tympanoplastica | |
| 650 | 4 | |a sensorineural hearing loss | |
| 650 | 4 | |a vezetéses halláscsökkenés | |
| 650 | 4 | |a zárt technikájú tympnoplastica | |
| 650 | 7 | |a Bone Substitutes |2 NLM | |
| 650 | 7 | |a Dust |2 NLM | |
| 650 | 7 | |a bioactive glass S53P4 |2 NLM | |
| 700 | 1 | |a Szabó, Éva |e verfasserin |4 aut | |
| 700 | 1 | |a Szanyi, István |e verfasserin |4 aut | |
| 700 | 1 | |a Rostás, Tamás |e verfasserin |4 aut | |
| 700 | 1 | |a Pap, István |e verfasserin |4 aut | |
| 700 | 1 | |a Révész, Péter |e verfasserin |4 aut | |
| 700 | 1 | |a Kopjár, Eszter |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Orvosi hetilap |d 1949 |g 163(2022), 21 vom: 22. Mai, Seite 838-845 |w (DE-627)NLM000021601 |x 1788-6120 |7 nnns |
| 773 | 1 | 8 | |g volume:163 |g year:2022 |g number:21 |g day:22 |g month:05 |g pages:838-845 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1556/650.2022.32477 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 163 |j 2022 |e 21 |b 22 |c 05 |h 838-845 | ||